OREMAVEN
XMM 7,722.00 -2.63% YTD +5.6% OM ASX 450.55 -2.56% YTD +0.1% OM PRECIOUS 349.20 -2.24% YTD +2.5% OM EX-PREC 418.91 -2.72% YTD -1.1% XAU 4,115.59 +2.31% YTD -4.9% GLD 375.49 +0.81% YTD -5.2% GDX 85.75 +1.37% YTD -0.0% SIL 77.33 -1.00% YTD -7.3% COPX 70.23 -5.81% YTD -1.8% URNM 40.07 -2.79% YTD -27.0%
2026-11-06

← INR management

Full background report

April Hashimoto

Interim Chief Financial Officer

Career chronology

  • Current at evidence cutoff: Ioneer Ltd — Interim Chief Financial Officer. Annual Report 2025 (FY2025 annual report and later issuer leadership disclosures; interim CFO appointment.)

Suitability for the current role

Current role relevance is supported at title level

At evidence cutoff · analyst inference · medium materiality

Analyst inference: the disclosed current title indicates experience relevant to the assigned function. The record reviewed does not establish individual delivery outcomes or independently verify credentials beyond the cited issuer disclosure.

Attribution: Responsibility not applicable. This is an analytical role-fit judgment, not a claim of proven performance.

Relevance: Current role scope is directly relevant to team composition; evidence of delivery remains limited.

Annual Report 2025 (FY2025 annual report and later issuer leadership disclosures; interim CFO appointment.)

Evidence gaps

  • Independent verification of the complete career chronology, education and professional memberships is not established by the sources reviewed.

  • No comprehensive regulator, court, safety, environment or litigation-record review was completed; absence of a finding here is not a clearance.

  • Individual contribution to employer outcomes and concurrent board interests require additional source-level verification.